Cue Biopharma's total assets for Q4 2025 were $42.21M, an increase of 33.40% from the previous quarter. CUE total liabilities were $15.78M for the fiscal quarter, a -14.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.